Ubs Asset Management Americas Inc Bionano Genomics, Inc. Transaction History

Ubs Asset Management Americas Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.06 - $1.97 $148,981 - $276,881	-140,549 Reduced 41.22%	200,389 $222,000
Q3 2022 Nov 14, 2022	BUY	$0.36 - $36.0 $207 - $20,700	575 Added 0.17%	340,938 $0
Q2 2022 Aug 12, 2022	BUY	$12.3 - $27.3 $874,493 - $1.94 Million	71,097 Added 26.4%	340,363 $0
Q4 2021 Feb 14, 2022	BUY	$29.9 - $61.2 $1.23 Million - $2.51 Million	41,076 Added 18.0%	269,266 $0
Q3 2021 Nov 15, 2021	BUY	$51.4 - $68.2 $366,379 - $486,129	7,128 Added 3.22%	228,190 $0
Q2 2021 Aug 16, 2021	BUY	$44.1 - $84.0 $9.75 Million - $18.6 Million	221,062 New	221,062 $0

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $81.2M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.